All In Biotech

Drug Trial Radar · NCT00107835

Safety Study of S-Caine Peel (Skin Numbing Cream) Before a Painful Dermatologic Procedure in Adults

An Open-Label Safety Study to Evaluate the Use of S-Caine™ Peel (Lidocaine 7% and Tetracaine 7% Cream) in Adult Patients Undergoing a Minor or Major Dermal Procedure

Last checked: Nov 20, 2026Latest source record: Jun 6, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

408

Actual

Start

May 2005

Primary completion

Sep 2005

Study completion Sep 2005

Sponsor

Lead sponsor
ZARS Pharma Inc.Industry
Sponsor type
Industry
First posted
Apr 11, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety of one treatment of S-Caine™ Peel (skin numbing cream) applied on healthy skin before a painful dermatologic procedure in adults. This study will also evaluate how well the S-Caine™ Peel eases the pain of the procedure.

Conditions

  • Pain

Interventions

  • S-Caine™ Peel (lidocaine and tetracaine cream 7%/7%)Drug

    S-Caine Peel comprising a 1:1 eutectic mixture of 7% lidocaine, and 7% tetracaine was applied topically. The study drug remained on the treatment area for 20-30 minutes for minor dermal procedures and 60 minutes for major dermal procedures

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants with adverse eventsTime frame: 20-30 minutes

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • International Dermatology Research Inc.

    Miami, Florida

  • Midwest Cutaneous Research

    Clinton Township, Michigan

  • Laser and Skin Surgery Center of New York

    New York, New York

  • Tennessee Clinical Research Center

    Nashville, Tennessee

  • Texas Dermatology Research Institute

    Dallas, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.